regulation

On 21 August 2026 the FDA issued Marketing Granted Orders for 11 ZYN Ultra nicotine pouches from Swedish Match USA — ten 9mg flavours and a new 11mg Smooth. The authorizations push the total of FDA-authorized nicotine pouch products to 43, with 23 cleared through the agency’s nicotine pouch pilot program. The American Lung Association attacked the move, citing youth appeal.

regulation

The FDA issued Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch products on 30 June 2026 — the first time any nicotine pouch has been cleared to advertise reduced disease risk versus cigarettes. The authorised claim covers mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. Public health experts say the labelling could normalise nicotine for new users — and point to 460,000 youth pouch users as evidence the category is already reaching kids.

wellbeing

Dave Asprey says nicotine can reverse Alzheimer's. Tucker Carlson called ZYN 'lifesaving.' A wave of wellness influencers is reframing nicotine pouches as a 'natural' health hack — and researchers say the claims are outpacing the evidence by a wide margin.

market

NELK's FULL SEND brand entered the nicotine pouch market with 8 flavors and 4mg/8mg strengths, US-made and sold direct. The soft launch sold out, and 7 in 10 buyers locked in a monthly subscription before inventory cleared.

regulation

A federal appeals court ruled the FDA exceeded its authority by requiring 11 graphic cigarette warnings — Congress only authorized nine. The same legal theory — that the agency went beyond what Congress allowed — is being used to challenge the FDA’s nicotine pouch enforcement guidance in a separate lawsuit.

science

A 24-week randomised trial funded by Altria found that adult smokers who switched to on! nicotine pouches had significantly less gum inflammation, bleeding, and tooth staining than those who kept smoking. Every author is an Altria employee or paid consultant — so the caveats matter as much as the results.

science

A review in Nature Reviews Cardiology maps a hierarchy of vascular harm across every nicotine product. Nicotine pouches sit at the bottom — least harmful among nicotine products — but impair endothelial function, raise oxidative stress and arterial stiffness, and have no long-term outcome data.

wellbeing

The pouch delivery mechanism that Zyn made famous is now being copied by wellness brands — minus the nicotine. Ultra raised $11M and sold a million cans in six months. Blip, IQ Pouch, and Plopii are all betting the format works for focus, sleep, and calm.

regulation

Trump has tapped White House health aide Dr. Heidi Overton to run the FDA. She'd inherit a controversial policy that lets some unauthorized nicotine pouches stay on sale while their applications sit pending — and she hasn't said whether she'd keep it.

market

ZYN added three new permanent fruit flavors to its US lineup — Black Cherry, Peach, and Dragonberry — in 3mg and 6mg, bringing the dry mini-pouch range to 26 variants. US buyers had previously imported European ZYN fruit cans to get past mint and citrus. The expansion lands as Velo Plus and On! Plus eat into ZYN's share.

market

FRE — the Turning Point Brands nicotine pouch brand — launched FRE Labs, a limited-edition flavor platform where adult consumers vote on which small-batch flavors join the permanent lineup. The first drop, Blackberry Lemon Ice, is part of a new "Ice" line in 6mg and 12mg strengths, sold online only.

science

Nicotine pouch cans label strength in milligrams per gram, milligrams per pouch, or vague terms like “extra strong.” A pouch labelled 20 mg/g holds 14 mg per pouch, not 20. Here’s why the labels are inconsistent, what science says about actual nicotine content, and how regulators are starting to fix it.

market

ALP — the Tucker Carlson-backed pouch brand owned by Turning Point Brands — has launched the Frontier Collection: three new limited-edition flavors (Cowboy Coffee, Campfire Cinnamon, Sunset Mango) in 4mg and 8mg strengths. The brand calls it its biggest release to date, backed by a Western-themed campaign with creator Dave "Heavy D" Sparks.

market

The Alabama Department of Corrections is banning tobacco across all state prisons starting September 1 — but ZYN nicotine pouches and NicoDerm patches stay in canteens. The policy affects 21,000+ inmates and separates tobacco from nicotine in a way no other state prison system has.

regulation

Starting September 1, 2026, New York extends its 75% wholesale tobacco tax to nicotine pouches — treating Zyn, On!, and Velo like cigars even though they contain no tobacco. Every seller must be licensed as a tobacco dealer, and a floor tax on existing inventory is due September 21.

market

A Reuters analysis reveals PMI's U.S. nicotine pouch business generates 8 times the gross profit per thousand units of its international cigarette business. BAT forecasts the pouch market reaching £11 billion by 2030 — overtaking vapes. But can the category travel beyond Scandinavia and the U.S.?

product

Chemular's Safeguard Mark I adds child-resistant packaging to existing nicotine pouch cans without a redesign — responding to FDA pressure after poison-control data showed 72% of pouch exposures involved children under 5. All 20 FDA-authorized pouch products already use CRC packaging.

science

A BAT-funded study in BMC Chemistry measured 132 chemicals across 11 nicotine pouches, two snus products and cigarette-smoke data. Pouches came out with fewer detectable toxicants and over 90% lower levels than snus in most tests — but nine of the pouches tested were Velo, made by the funder.

science

A peer-reviewed review in Frontiers in Oral Health finds nicotine pouches remove the combustion that drives smoking-related oral cancer, but no long-term data exists to say what they mean for cancer risk. A separate UK dental-team update flags mucosal lesions and gum recession among users.

market

The crew behind NELK — already behind Happy Dad hard seltzer — has extended its Full Send brand into tobacco-free nicotine pouches: eight flavors, 0/4/8mg, $6 a can, made in the USA, ships to 31 states. Here's what the creator brand actually sells.

market

Philip Morris International has opened a $1.2 billion ZYN manufacturing campus in Aurora, Colorado — its largest US facility and the biggest bet yet on nicotine pouch production. The 780,000-square-foot plant employs 500 people and began commercial output in July 2026.

market

Haypp Group, the largest online nicotine pouch retailer, grew Q2 net sales 28% to SEK 1.18bn as nicotine pouch volume rose 45% and the US and UK each more than doubled. But profit for the quarter came in at SEK 0.0mn as the company poured marketing and personnel spend into growth markets — and launched Saudi Arabia, which it calls the world's second-largest nicotine pouch market.

product

Philip Morris launched ZYN Ultra in the US in June 2026 — a moist, slim pouch line in 9mg and 11mg, 20 pouches per can, eight flavours, at a lower per-pouch price than flagship dry ZYN. It is PMI's biggest ZYN format change yet, built to slow share losses to Velo Plus, FRE and ALP.

science

The first Cochrane review of oral nicotine pouches as a quitting aid found only four tiny studies covering 284 people — and rated its confidence in the findings as 'very low'. Here's what we actually know.

market

Altria's On! shipped 47.2 million cans in Q2 2026, up 17% sequentially, but its U.S. retail share fell to 13.9% in H1 (from 16.8% a year ago) as the $13.4B pouch category grows faster than On! can capture it.

market

Philip Morris International's ZYN US shipments grew just 1.8% in Q2 2026 — down from 37% annual growth in 2025 — as BAT's Velo Plus and Altria's On! Plus gain share in the $7 billion nicotine pouch market. PMI's response: ZYN ULTRA and a historic FDA modified-risk authorization.

trend

Ultra raised $11M and sold 1 million cans in six months. Blip landed in 7,000+ stores. The pouch format Zyn made mainstream is now the delivery mechanism for nootropics, not nicotine.

market

BAT says Modern Oral revenue rose 65.9% in the first half, putting VELO at the center of its smokeless growth strategy.

science

The FDA just released Wave 8 of the PATH Study, the federal government's most comprehensive look at nicotine pouch usage in America. Here's what the data covers.

regulation

The FDA just authorized four new on! nicotine pouch products, explicitly citing lower levels of harmful constituents compared to traditional oral tobacco. It's the first authorization of its kind — and it opens the door for pouches to claim harm reduction.